Key facts
- Bcmaterial China’s last known valuation is $1.0B (Mar 2023).
- It has raised $217.7M; the latest was PE Growth/Expansion in Dec 2025.
- Notable investors include Suzhou Guofa Venture Capital, China V Fund, Shandong Railway Development Fund, Wuxi Industry Development Group, Shenzhen Qianhai Sairui Fund Management — 19 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 19 names
- ·Watchlist + deal alerts for Bcmaterial China
- ·The full record, as it builds
Funding rounds
No funding rounds for Bcmaterial China are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Bcmaterial China
Manufacturer of electronic chemicals intended for the semiconductor and electronics industry. The company's range of products includes photoresists, photoresist monomers and photoresist resins, thereby supporting advanced manufacturing processes to enhance precision, reliability, and performance in electronic component production.
- Sector
- Materials and Resources
- HQ
- Pizhou, China
- Founded
- 2010
- Employees
- 260
- Website
- bcpharma.com/
- Ownership
- Privately Held (backing)
Bcmaterial China doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Bcmaterial China shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Bcmaterial China in its N-PORT filings yet. We sweep new filings monthly.